USRE46621E1 - Processes for preparing isoquinolinones and solid forms of isoquinolinones - Google Patents

Processes for preparing isoquinolinones and solid forms of isoquinolinones Download PDF

Info

Publication number
USRE46621E1
USRE46621E1 US15/051,529 US201615051529A USRE46621E US RE46621 E1 USRE46621 E1 US RE46621E1 US 201615051529 A US201615051529 A US 201615051529A US RE46621 E USRE46621 E US RE46621E
Authority
US
United States
Prior art keywords
polymorph
compound
formula
following characteristic
peaks
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active, expires
Application number
US15/051,529
Inventor
Pingda Ren
Michael Martin
Paul Isbester
Benjamin S. Lane
Jason Kropp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Infinity Pharmaceuticals Inc
Original Assignee
Infinity Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US201161431304P priority Critical
Priority to US201161578655P priority
Priority to US13/347,423 priority patent/US8809349B2/en
Priority to US15/051,529 priority patent/USRE46621E1/en
Application filed by Infinity Pharmaceuticals Inc filed Critical Infinity Pharmaceuticals Inc
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46491229&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=USRE46621(E1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application granted granted Critical
Publication of USRE46621E1 publication Critical patent/USRE46621E1/en
Assigned to HCR COLLATERAL MANAGEMENT, LLC reassignment HCR COLLATERAL MANAGEMENT, LLC INTELLECTUAL PROPERTY SECURITY AGREEMENT Assignors: INFINITY PHARMACEUTICALS, INC.
Assigned to INTELLIKINE LLC reassignment INTELLIKINE LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: REN, PINGDA, MARTIN, MICHAEL
Assigned to INTELLIKINE, INC. reassignment INTELLIKINE, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ALBANY MOLECULAR RESEARCH, INC.
Assigned to INFINITY PHARMACEUTICALS, INC. reassignment INFINITY PHARMACEUTICALS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: INTELLIKINE LLC
Assigned to INTELLIKINE LLC reassignment INTELLIKINE LLC CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: INTELLIKINE, INC.
Assigned to ALBANY MOLECULAR RESEARCH, INC. reassignment ALBANY MOLECULAR RESEARCH, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ISBESTER, PAUL
Assigned to INFINITY PHARMACEUTICALS, INC. reassignment INFINITY PHARMACEUTICALS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KROPP, Jason, LANE, BENJAMIN S.
Active legal-status Critical Current
Adjusted expiration legal-status Critical

Links